Draft Genome of the Multidrug-Resistant Acinetobacter baumannii Strain A155 Clinical Isolate

Brock A Arivett; Steven E Fiester; David C Ream; Daniela Centrón; Maria S Ramírez; Marcelo E Tolmasky; Luis A Actis

doi:10.1128/genomeA.00212-15

Draft Genome of the Multidrug-Resistant Acinetobacter baumannii Strain A155 Clinical Isolate

Genome Announc. 2015 Mar 26;3(2):e00212-15. doi: 10.1128/genomeA.00212-15.

Authors

Brock A Arivett¹, Steven E Fiester¹, David C Ream¹, Daniela Centrón², Maria S Ramírez³, Marcelo E Tolmasky³, Luis A Actis⁴

Affiliations

¹ Department of Microbiology, Miami University, Oxford, Ohio, USA.
² Instituto de Microbiología y Parasitología Médica, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Tecnológicas, Buenos Aires (IMPaM, UBA-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
³ Department of Biological Science, Center for Applied Biotechnology Studies, California State University Fullerton, Fullerton, California, USA.
⁴ Department of Microbiology, Miami University, Oxford, Ohio, USA actisla@miamioh.edu.

Abstract

Acinetobacter baumannii is a bacterial pathogen with serious implications on human health, due to increasing reports of multidrug-resistant strains isolated from patients. Total DNA from the multidrug-resistant A. baumannii strain A155 clinical isolate was sequenced to greater than 65× coverage, providing high-quality contig assemblies.

Grants and funding

R15 AI047115/AI/NIAID NIH HHS/United States